Loading
Latest filing published 05 Oct 2015 for Medite Cancer Diagnostics, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Michaela Ott in Medite Cancer Diagnostics, Inc. In total, 2 filings cover trades dated 5 October 2015.
No open-market sale appears; the market trades are 2 purchases. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 5 October 2015 came the latest disclosure, an open-market purchase in Medite Cancer Diagnostics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations